ARDELYX, INC. (ARDX) Form 10-Q Quarterly Reports
ARDELYX, INC. (ARDX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARDX
CIK: 1437402
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerPamela Kelleher
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0002093095-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0002044416-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001308911-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0002088887-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0002034148-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001987188-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001869194-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001321402-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0002093095-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001987188-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001321402-26-000017 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001869194-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0002044416-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001308911-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0002088887-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0002034148-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-11 | 8-K | 0001193125-26-354026 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097075 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0001104659-26-094212 | View SEC Doc Filr Page |
| S-8 | 2026-08-10 | — | S-8 | 0001437402-26-000049 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001437402-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001437402-26-000043 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | FORM 4 | 0001321402-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-29 | 8-K | 0001437402-26-000033 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001869194-26-000008 | View SEC Doc Filr Page |